High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy
NCT00212901
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Diabetic Kidney Disease
Interventions
DRUG:
High dose ACE-I vs ARB
Sponsor
Ottawa Hospital Research Institute